Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
42.05
+2.40 (6.05%)
Nov 9, 2026, 4:00 PM EST - Market closed
Rigel Pharmaceuticals Employees
As of December 31, 2025, Rigel Pharmaceuticals had 174 total employees, including 172 full-time and 2 part-time employees. The number of employees increased by 10 or 6.10% compared to the previous year. That makes Rigel Pharmaceuticals the 27,822nd largest employer in the world and 3,508th in the United States.
Employees
174
Change (1Y)
10
Growth (1Y)
6.10%
Revenue / Employee
$1,656,397
Profits / Employee
$1,765,483
Market Cap
791.80M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 174 | 10 | 6.10% | 172 | 2 |
| Dec 31, 2024 | 164 | 17 | 11.56% | 162 | 2 |
| Dec 31, 2023 | 147 | -8 | -5.16% | 147 | 0 |
| Dec 31, 2022 | 155 | -10 | -6.06% | 155 | 0 |
| Dec 31, 2021 | 165 | -4 | -2.37% | 165 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Ginkgo Bioworks Holdings | 485 |
| Alumis | 239 |
| Sana Biotechnology | 142 |
| Solid Biosciences | 121 |
| Cullinan Therapeutics | 109 |
| Annexon | 92 |
| OmniAb | 89 |
RIGL News
- 23 hours ago - Rigel Pharmaceuticals price target raised to $86 from $83 at Citi - TheFly
- 3 days ago - Rigel Pharmaceuticals price target raised to $47 from $43 at Cantor Fitzgerald - TheFly
- 4 days ago - Rigel Pharmaceuticals Earnings Call Transcript: Q3 2026 - Transcripts
- 4 days ago - Rigel Pharmaceuticals Quarterly report: Q3 2026 - Filings
- 4 days ago - Rigel Pharmaceuticals Earnings release: Q3 2026 - Filings
- 4 days ago - Rigel Pharmaceuticals Slides: Q3 2026 - Filings
- 4 days ago - Rigel Pharmaceuticals narrows 2026 revenue view to $290M-$295M from $285M-$295M - TheFly
- 4 days ago - Rigel Pharmaceuticals reports Q3 EPS 65c, consensus 96c - TheFly